Note 5. Inventories

The components of inventories are as follows:


	September 30, 2015		March 31, 2015
	(in $000’s)
Raw materials and supplies	$	8,479	$	7,417
Work-in-progress		9,358		6,466
Finished goods		5,195		2,891

	$	23,032	$	16,774

The Company’s inventories relate to its circulatory care product lines, primarily its Impella^® heart pump product platforms. Finished goods and work-in-process inventories consist of direct material, labor and overhead. During the six months ended September 30, 2015 and 2014, the Company recorded $1.0 million and $0.6 million, respectively, in write-downs of inventory.